Evaluation of the feasibility and efficacy of point-of-care antibody tests for biomarker guided management of COVID-19

Biomarker guided therapy could improve management of COVID-19 inpatients. Although some results indicate that antibody tests are prognostic, little is known about patient management using point-of-care (POC) antibody tests. COVID-19 inpatients were recruited to evaluate 2 POC tests: LumiraDX and Rig...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Journal of infectious diseases 2024-09
Hauptverfasser:	Reilly, Cavan, Mylonakis, Eleftherios, Dewar, Robin, Young, Barnaby, Nordwall, Jacqueline, Bhagani, Sanjay, Chia, Po-Ying, Davis, Ruby, Files, Clark, Ginde, Adit A, Hatlen, Timothy, Helleberg, Marie, Hayanga, Awori, Jensen, Tomas O, Jain, Mamta K, Kalomenidis, Ioannis, Kim, Kami, Lallemand, Perrine, Lindegaard, Birgitte, Menon, Anupama, Ognenovska, Katherine, Poulakou, Garyfallia, Thorup Røge, Birgit, Rogers, Angela J, Shaw-Saliba, Katy, Sandkovsky, Uriel, Trautner, Barbara W, Vasudeva, Shikha S, Vekstein, Andrew, Viens, Kimberley, Wyncoll, James, DuChateau, Brian, Zhang, Zhenxing, Wu, Shujiang, Babiker, Abdel G, Davey, Victoria, Gelijns, Annetine, Higgs, Elizabeth, Kan, Virginia, Lundgren, Jens, Matthews, Gail V, Lane, H Cliff
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!